2014 has been a breakthrough year for hepatitis C treatment, with many new drugs to treat and cure the virus. Here’s an update on some of the major studies so far.
The risk of developing drug resistance does not appear to be greater for those on PrEP who may not be adhering properly, according to results from the iPrEx study.
A recent study suggests that smoking in HIV-positive individuals causes increased immune activation, microbial translocation and impairment of CD4-cell functions that could influence disease progression and management.
More than two thirds of new hepatitis C cases are found in baby boomers, prompting a decision by the U.S. Centers for Medicare and Medicaid Services to pay for screenings.
A South African study finds a more-than-double herpes simplex virus rates in HIV-positive women compared to negative women.
DOWNLOAD THEBODYPRO.COM’S MOBILE APP
Get your clinical headline fix while you’re on the go with TheBodyPRO.com’s app for iPhones and Android devices!
This app will help health care professionals such as yourself keep up to date with the latest in HIV research, news, conference coverage, interviews and more by bringing the best of TheBodyPRO.com’s content directly to your phone.
Vitamin D Deficiency When Starting Treatment Linked With Increased HIV Progression
Recapping 2014 Hepatitis C Treatment Research Thus Far
Taking PrEP Does Not Increase Drug Resistance Risk
Prostate Cancer Risk Lower for Men Living With HIV
Tobacco Smoking Impairs Immune System in People Living With HIV
HIV Criminalization: A Physician’s Perspective
Medicare Will Pay for Hepatitis C Screenings for Baby Boomers
South Africa: Herpes Infections Higher in Women With HIV
